|
1
|
Leemans CR, Snijders PJ and Brakenhoff RH:
The molecular landscape of head and neck cancer. Nat Rev Cancer.
18:269–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu YJ, Chen J, Zhong WS, Ling TY, Jian XC,
Lu RH, Tang ZG and Tao L: Trend analysis of Betel Nut-associated
oral cancer and health Burden in China. Chin J Dent Res. 20:69–78.
2017.PubMed/NCBI
|
|
3
|
Gillison ML, Koch WM, Capone RB, Spafford
M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et
al: Evidence for a causal association between human papillomavirus
and a subset of head and neck cancers. J Natl Cancer Inst.
92:709–720. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Syrjänen S: Human papillomavirus (HPV) in
head and neck cancer. J Clin Virol. 32 (Suppl 1):S59–S66. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Rorke MA, Ellison MV, Murray LJ, Moran
M, James J and Anderson LA: Human papillomavirus related head and
neck cancer survival: A systematic review and meta-analysis. Oral
Oncol. 48:1191–1201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sabatini ME and Chiocca S: Human
papillomavirus as a driver of head and neck cancers. Br J Cancer.
122:306–314. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quabius ES, Haag J, Kühnel A, Henry H,
Hoffmann AS, Görögh T, Hedderich J, Evert M, Beule AG, Maune S, et
al: Geographical and anatomical influences on human papillomavirus
prevalence diversity in head and neck squamous cell carcinoma in
Germany. Int J Oncol. 46:414–422. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anantharaman D, Abedi-Ardekani B, Beachler
DC, Gheit T, Olshan AF, Wisniewski K, Wunsch-Filho V, Toporcov TN,
Tajara EH, Levi JE, et al: Geographic heterogeneity in the
prevalence of human papillomavirus in head and neck cancer. Int J
Cancer. 140:1968–1975. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lassen P, Lacas B, Pignon JP, Trotti A,
Zackrisson B, Zhang Q, Overgaard J and Blanchard P; MARCH
Collaborative Group, : Prognostic impact of HPV-associated
p16-expression and smoking status on outcomes following
radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
Radiother Oncol. 126:107–115. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoffmann M, Quabius ES, Tribius S,
Gebhardt S, Görögh T, Hedderich J, Huber K, Dunst J and Ambrosch P:
Influence of HPV-status on survival of patients with tonsillar
carcinomas (TSCC) treated by CO2-laser surgery plus risk adapted
therapy-A 10 year retrospective single centre study. Cancer Lett.
413:59–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Quabius ES, Tribius S, Heinrichs A, Haaser
D, Kühnel A, Laudien M, Hoppe F, Mlynski R, Ambrosch P and Hoffmann
M: HPV DNA/RNA detection in various oral and oropharyngeal
biomaterials identifies active HPV infections also in
non-neoplastic tonsils. Transl Oncol. 14:1010022021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoffmann M, Quabius ES, Fabian A, Laudien
M and Ambrosch P: The interaction of smoking habit, SLPI and AnxA2
in HPV associated head and neck and other cancers. Cancer Treat Res
Commun. 26:1002992021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Woodham AW, Da Silva DM, Skeate JG, Raff
AB, Ambroso MR, Brand HE, Isas JM, Langen R and Kast WM: The
S100A10 subunit of the Annexin A2 heterotetramer facilitates
L2-mediated human papillomavirus infection. PLoS One. 7:e435192012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dziduszko A and Ozbun MA: Annexin A2 and
S100A10 regulate human papillomavirus type 16 entry and
intracellular trafficking in human keratinocytes. J Virol.
87:7502–7515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Taylor JR, Fernandez DJ, Thornton SM,
Skeate JG, Lühen KP, Da Silva DM, Langen R and Kast WM:
Heterotetrameric Annexin A2/S100A10 (A2t) is essential for
oncogenic human papillomavirus trafficking and capsid disassembly,
and protects virions from lysosomal degradation. Sci Rep.
8:116422018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bouloukaki I, Tsiligianni IG, Tsoumakidou
M, Mitrouska I, Prokopakis EP, Mavroudi I, Siafakas NM and Tzanakis
N: Sputum and nasal lavage lung-specific biomarkers before and
after smoking cessation. BMC Pulm Med. 11:352011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meyer M, Bauer RN, Letang BD, Brighton L,
Thompson E, Simmen RC, Bonner J and Jaspers I: Regulation and
activity of secretory leukoprotease inhibitor (SLPI) is altered in
smokers. Am J Physiol Lung Cell Mol Physiol. 306:L269–L276. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma G, Greenwell-Wild T, Lei K, Jin W,
Swisher J, Hardegen N, Wild CT and Wahl SM: Secretory leukocyte
protease inhibitor binds to annexin II, a cofactor for macrophage
HIV-1 infection. J Exp Med. 200:1337–1346. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Drannik AG, Henrick BM and Rosenthal KL:
War and Peace between WAP and HIV: Role of SLPI, Trappin-2, Elafin
and Ps20 in susceptibility to HIV infection. Biochem Soc Trans.
39:1427–1432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Woodham AW, Sanna AM, Taylor JR, Skeate
JG, Da Silva DM, Dekker LV and Kast WM: Annexin A2 antibodies but
not inhibitors of the Annexin A2 heterotetramer impair productive
HIV-1 infection of macrophages in vitro. Virol J. 13:1872016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martin-Gomez L, Fulp WJ, Schell MJ, Sirak
B, Abrahamsen M, Isaacs-Soriano KA, Lorincz A, Wenig B, Chung CH,
Caudell JJ and Giuliano AR: Oral gargle-tumor biopsy human
papillomavirus (HPV) agreement and associated factors among
oropharyngeal squamous cell carcinoma (OPSCC) cases. Oral Oncol.
92:85–91. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Majchrzak Gorecka M, Majewski P, Grygier
B, Murzyn K and Cichy J: Secretory leukocyte protease inhibitor
(SLPI), a multi-functional protein in the host defense response.
Cytokine Growth Factor Rev. 28:79–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Klingenberg B, Hafkamp HC, Haesevoets A,
Manni JJ, Slootweg PJ, Weissenborn SJ, Klussmann JP and Speel EJ:
p16 INK4A overexpression is frequently detected in tumour free
tonsil tissue without association with HPV. Histopathology.
56:957–967. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Quabius ES, Ossenkop L, Harder S and Kern
M: Dental implants stimulate expression of interleukin-8 and its
receptor in human blood-an in vitro approach. J Biomed Mater Res B
Appl Biomater. 100:1283–1288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cordes C, Häsler R, Werner C, Görögh T,
Röcken C, Hebebrand L, Kast WM, Hoffmann M, Schreiber S and
Ambrosch P: The level of secretory leukocyte protease inhibitor is
decreased in metastatic head and neck squamous cell carcinoma. Int
J Oncol. 39:185–191. 2011.PubMed/NCBI
|
|
28
|
Remmerbach TW, Brinckmann UG, Hemprich A,
Chekol M, Kühndel K and Liebert UG: PCR detection of human
papillomavirus of the Mucosa: Comparison between MY09/11 and
GP5+/6+ primer sets. J Clin Virol. 30:302–308. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chaturvedi AK, Song H, Rosenberg P,
Ramqvist T, Anderson WF, Munck-Wikland E, Ye W and Dalianis T:
Tonsillectomy and incidence of oropharyngeal cancers. Cancer
Epidemiol Biomarkers Prev. 25:944–950. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Windfuhr JP, Schloendorff G, Sesterhenn
AM, Prescher A and Kremer B: A devastating outcome after
adenoidectomy and tonsillectomy: Ideas for improved prevention and
management. Otolaryngol Head Neck Surg. 140:191–196. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gallagher KE, LaMontagne DS and
Watson-Jones D: Status of HPV vaccine introduction and barriers to
country uptake. Vaccine. 36:4761–4767. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jit M, Brisson M, Portnoy A and Hutubessy
R: Cost-effectiveness of female human papillomavirus vaccination in
179 countries: A PRIME modelling study. Lancet Glob Health.
2:e406–e414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ng SS, Hutubessy R and Chaiyakunapruk N:
Systematic review of cost-effectiveness studies of human
papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral
and multiple age cohort vaccination. Vaccine. 36:2529–2544. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carpén T, Sjöblom A, Lundberg M, Haglund
C, Markkola A, Syrjänen S, Tarkkanen J, Mäkitie A, Hagström J and
Mattila P: Presenting symptoms and clinical findings in
HPV-positive and HPV-negative oropharyngeal cancer patients. Acta
Otolaryngol. 138:513–518. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Quabius ES, Loehr J, Haaser D, Günther V,
Maass N, Röcken C, Mathiak M, Alkatout I and Hoffmann M:
Smoking-induced SLPI expression hinders HPV infections also in
squamous cell carcinomas of the Vulva. Transl Oncol. 12:36–42.
2019. View Article : Google Scholar : PubMed/NCBI
|
